Clincosm LogoSign in Get a demo

Endometrial Adenocarcinoma

Showing 26 - 36 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +8 more
  • Brivanib Alaninate
  • Laboratory Biomarker Analysis
  • Aurora, Colorado
  • +34 more
Nov 2, 2017

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +8 more
  • Burbank, California
  • +58 more
Sep 8, 2017

Prognostic Biomarkers in Patients With Endometrial Cancer

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Aug 22, 2017

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Mar 17, 2016

Endometrial Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage I Uterine Sarcoma Trial in Philadelphia (Laparoscopic Surgery,

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Laparoscopic Surgery
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 27, 2015

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Philadelphia

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +5 more
  • Doxorubicin Hydrochloride
  • +4 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Apr 30, 2015

Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma Trial in Kingston

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +9 more
  • Kingston, Ontario, Canada
    National Cancer Institute of Canada Clinical Trials Group
Feb 5, 2015

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Dec 29, 2014

Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma, Fallopian Tube Carcinoma Trial in United States (Paclitaxel,

Completed
  • Chemotherapeutic Agent Toxicity
  • +14 more
  • Chicago, Illinois
  • +6 more
Dec 29, 2014

Atypical Endometrial Hyperplasia, Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma Trial (drug, device, other)

Withdrawn
  • Atypical Endometrial Hyperplasia
  • +10 more
  • megestrol acetate
  • +3 more
  • (no location specified)
Sep 9, 2014

Endometrial Adenoacanthoma, Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma Trial in Philadelphia

Completed
  • Endometrial Adenoacanthoma
  • +5 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jan 23, 2013